Mongon Thibaut 4

4 · Kenvue Inc. · Filed Feb 18, 2025

Form 4

Period: 2025-02-13

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Restricted Stock Units
2025-02-13−8,438→ 8,438 total
→ Common Stock (8,438 underlying)
Exercise/Conversion
Restricted Stock Units
2025-02-14−23,195→ 0 total
→ Common Stock (23,195 underlying)
Exercise/Conversion
Common Stock
2025-02-13+8,438→ 124,219.84 total
Tax Payment
Common Stock
2025-02-13$21.23/sh−4,317$91,650→ 119,902.84 total
Exercise/Conversion
Common Stock
2025-02-14+23,195→ 143,097.84 total
Tax Payment
Common Stock
2025-02-14$21.75/sh−11,865$258,064→ 131,232.84 total
Exercise/Conversion
Common Stock
2025-02-14+139,170→ 270,402.84 total
Tax Payment
Common Stock
2025-02-14$21.75/sh−70,038$1,523,327→ 200,364.84 total
Exercise/Conversion
Restricted Stock Units
2025-02-14−139,170→ 0 total
→ Common Stock (139,170 underlying)

Footnotes (5)

[F1]The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.
[F2]Shares withheld for payment of taxes upon vesting of RSUs.
[F3]This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026 subject to the reporting person's continued service through the vesting date.
[F4]This award vested in full on 02/14/2025.
[F5]These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level.

Documents

1 file